Loading...
XMSM
GL9
Market cap2.81bUSD
Apr 02, Last price  
10.20EUR
1D
-0.58%
1Q
-24.56%
Jan 2017
-35.36%
Name

Glanbia PLC

Chart & Performance

D1W1MN
P/E
8.32
P/S
0.48
EPS
1.23
Div Yield, %
3.61%
Shrs. gr., 5y
-1.81%
Rev. gr., 5y
17.85%
Revenues
5.43b
-3.85%
1,753,645,0001,830,012,0001,853,427,0002,206,567,0002,232,161,0001,830,327,0002,166,695,0002,671,151,0002,211,757,0002,382,133,0002,538,368,0002,774,326,0002,847,892,0002,387,100,0002,386,300,0003,875,700,0003,823,100,0004,196,900,0005,642,400,0005,425,400,000
Net income
312m
+56.29%
61,119,00057,396,00065,934,00059,833,00078,399,000112,676,000108,047,000112,178,000143,790,000150,330,000165,129,507198,381,736222,775,651395,181,994267,673,301206,940,903174,514,563189,080,863199,600,000311,957,520
CFO
428m
+43.41%
67,053,000136,881,00034,782,00062,096,00090,082,00068,693,00069,646,000102,919,00073,046,000107,737,000173,648,000276,712,000322,909,00091,100,000275,100,000212,500,000277,400,000251,100,000298,300,000427,800,000
Dividend
Aug 22, 20240.1564 EUR/sh
Earnings
May 01, 2025

Profile

Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
URL
https://www.glanbia.com/
IPO date
Mar 01, 1988
Employees
6,163
Domiciled in
IE
Incorporated in
IE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,425,400
-3.85%
5,642,400
34.44%
Cost of revenue
4,956,200
5,348,613
Unusual Expense (Income)
NOPBT
469,200
293,787
NOPBT Margin
8.65%
5.21%
Operating Taxes
44,700
25,700
Tax Rate
9.53%
8.75%
NOPAT
424,500
268,087
Net income
311,958
56.29%
199,600
5.56%
Dividends
(97,200)
(88,900)
Dividend yield
2.41%
2.54%
Proceeds from repurchase of equity
(148,100)
(196,900)
BB yield
3.68%
5.62%
Debt
Debt current
129,000
276,000
Long-term debt
752,200
851,600
Deferred revenue
Other long-term liabilities
5,300
5,200
Net debt
320,851
476,444
Cash flow
Cash from operating activities
427,800
298,300
CAPEX
(74,200)
(68,900)
Cash from investing activities
84,000
176,700
Cash from financing activities
(358,969)
(390,200)
FCF
681,630
136,357
Balance
Cash
413,700
438,600
Long term investments
146,649
212,556
Excess cash
289,079
369,036
Stockholders' equity
1,850,600
1,686,448
Invested Capital
2,620,621
2,517,364
ROIC
16.52%
10.60%
ROCE
15.40%
9.74%
EV
Common stock shares outstanding
270,142
293,817
Price
14.91
25.08%
11.92
-3.09%
Market cap
4,027,818
15.00%
3,502,299
-3.09%
EV
4,348,669
3,986,043
EBITDA
618,200
436,287
EV/EBITDA
7.03
9.14
Interest
19,200
19,300
Interest/NOPBT
4.09%
6.57%